First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial

PURPOSE: Circulating tumor cells (CTCs) are prognostic biomarkers in metastatic breast cancer, but their role in predicting treatment outcomes in metastatic triple-negative breast cancer (mTNBC) is less clear. The tnAcity trial demonstrated a significant progression-free survival (PFS) benefit with...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Manag Res
Main Authors: Liu, Minetta C, Janni, Wolfgang, Georgoulias, Vassilis, Yardley, Denise A, Harbeck, Nadia, Wei, Xin, McGovern, Desmond, Beck, Robert
格式: Artigo
語言:Inglês
出版: Dove 2019
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913260/
https://ncbi.nlm.nih.gov/pubmed/31849532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S208712
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍